ATP13A2 regulates mitochondrial bioenergetics through macroautophagy
Mitochondrial dysfunction and autophagy are centrally implicated in Parkinson's disease (PD). Mutations in ATP13A2, which encodes a lysosomal P-type ATPase of unknown function, cause a rare, autosomal recessive parkinsonian syndrome. Lysosomes are essential for autophagy, and autophagic clearan...
Main Authors: | Aaron M. Gusdon, Jianhui Zhu, Bennett Van Houten, Charleen T. Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-03-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996111003901 |
Similar Items
-
A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers
by: Fabiana H.G. Farias, et al.
Published: (2011-06-01) -
α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)
by: Guillaume Daniel, et al.
Published: (2015-01-01) -
Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome
by: Anna Pietrzak, et al.
Published: (2019-09-01) -
Yeast as a Tool for Deeper Understanding of Human Manganese-Related Diseases
by: Louise Thines, et al.
Published: (2019-07-01) -
Correlation between mitochondrial dysfunction and the pathogenesis of Parkinson's disease
by: Xiao-yu LIU, et al.
Published: (2014-02-01)